End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.66 CNY | +1.64% | +3.22% | -17.52% |
29/04 | Healthcare Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
20/03 | Biggest cyberattacks in US healthcare sector | RE |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The opinion of analysts covering the stock has improved over the past four months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company sustains low margins.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Home Furnishings
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-17.52% | 673M | - | ||
+5.93% | 9.04B | B | ||
+2.29% | 3.94B | C- | ||
+16.52% | 1.95B | - | ||
-3.90% | 1.46B | B- | ||
+45.13% | 1.26B | - | ||
-27.51% | 1.18B | C+ | ||
+13.40% | 1.01B | - | ||
+9.27% | 900M | - | ||
-7.89% | 825M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603313 Stock
- Ratings Healthcare Co.,Ltd.